Abstract:Endoplasmic reticulum (ER) stress is a key link between obesity, insulin resistance, and type 2 diabetes. Here, we provide evidence that this mechanistic link can be exploited for therapeutic purposes with orally active chemical chaperones. 4-Phenyl butyric acid and taurine-conjugated ursodeoxycholic acid alleviated ER stress in cells and whole animals. Treatment of obese and diabetic mice with these compounds resulted in normalization of hyperglycemia, restoration of systemic insulin sensitivity, resolution of fatty liver disease, and enhancement of insulin action in liver, muscle, and adipose tissues. Our results demonstrate that chemical chaperones enhance the adaptive capacity of the ER and act as potent antidiabetic modalities with potential application in the treatment of type 2 diabetes.

What problem does this paper attempt to address?

This paper aims to explore the potential applications of chemical chaperones (such as 4 - phenylbutyric acid and tauroursodeoxycholic acid) in the treatment of type 2 diabetes. Specifically, the problems that the researchers are trying to solve are: 1. **The relationship between endoplasmic reticulum stress and type 2 diabetes**: Endoplasmic reticulum (ER) stress is widespread in obese and type 2 diabetes patients, and this stress state is considered to be one of the key factors leading to insulin resistance and type 2 diabetes. The researchers hope to verify this hypothesis through experiments and explore whether insulin sensitivity and blood - glucose control can be improved by reducing endoplasmic reticulum stress. 2. **The mechanism of action of chemical chaperones**: The researchers hope to understand how these chemical chaperones reduce endoplasmic reticulum stress in cell and animal models, and their specific effects on the insulin signaling pathway. 3. **The feasibility of clinical application**: The researchers also hope that experimental data will support the feasibility of these chemical chaperones as a new method for treating type 2 diabetes, especially considering that these compounds have been used clinically for the treatment of other diseases and have good safety. Through these studies, the authors hope to provide new ideas and methods for the treatment of type 2 diabetes.

Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes